(Q51553963)

7 April 2018

title

Gamma-glutamyl transpeptidase and the metabolic syndrome. (English)

1 reference

7 April 2018

1 reference

Rantala AO

1

1 reference

7 April 2018

Lilja M

2

1 reference

7 April 2018

Kauma H

3

1 reference

7 April 2018

Savolainen MJ

4

1 reference

7 April 2018

Reunanen A

5

1 reference

7 April 2018

Kesäniemi YA

6

1 reference

7 April 2018

language of work or name

English

0 references

publication date

1 September 2000

1 reference

7 April 2018

Journal of Internal Medicine

published in

1 reference

7 April 2018

volume

248

1 reference

7 April 2018

issue

3

1 reference

7 April 2018

page(s)

230-238

1 reference

7 April 2018

Banting lecture 1988. Role of insulin resistance in human disease

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2000.00723.X

Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2000.00723.X

Glucose Intolerance and Aging: Evidence for Tissue Insensitivity to Insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2000.00723.X

Prevalence of the metabolic syndrome in drug-treated hypertensive patients and control subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2000.00723.X

The risk of determining risk with multivariable models

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2000.00723.X

Insulin release and peripheral sensitivity at the oral glucose tolerance test.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2000.00723.X

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2000.00723.X

Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2000.00723.X

Immunohistochemical detection of gamma-glutamyl transpeptidase in normal human tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2000.00723.X

von Willebrand factor, endothelial cell damage and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2000.00723.X

Serum gamma glutamyl transpeptidase in relation to alcohol consumption

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2000.00723.X

Characteristics of the ‘Metabolic Syndrome X’ in a cardiovascular low risk population in Crete

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2000.00723.X

Light-to-moderate alcohol intake is associated with enhanced insulin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2000.00723.X

Influence of carboxyhemoglobin, gamma-glutamyl-transferase, body weight, and heart rate on blood pressure in middle-aged men

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2000.00723.X

Prospective Study of Serum -Glutamyltransferase and Risk of NIDDM

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2000.00723.X

10.1046/J.1365-2796.2000.00723.X

21 January 2018

Identifiers

DOI

1 reference

7 April 2018

1 reference

7 April 2018